Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.) Cepheid (U.S.), Danaher Corporation (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Siemens AG (Germany)
(PRWEB) January 15, 2015
The report on the Microbiology Testing Market provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global microbiology testing market along with the estimates and forecasts of the revenue and market share analysis.
Browse 81 market data tables and 121 figures spread through 200 pages and in-depth TOC on “Microbiology Testing/Clinical Microbiology Market"
Early buyers will receive 10% customization on reports.
The global clinical microbiology market is expected to reach $12,411.36 million in 2019 from $6,727.29 million in 2014, at a CAGR of 13.03% between 2014 and 2019.
The microbiology testing market is segmented on the basis of applications into clinical, energy, environment, food, manufacturing and pharmaceuticals. The pharmaceuticals application segment accounted for the largest share of the microbiology market in 2014, while the food application segment is expected grow at the highest CAGR between 2014 and 2019.
For Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=219135367
The clinical microbiology market is segmented on the basis of products into consumables and instruments. Each of these market segments is further divided into multiple product segments and subsegments. The microbiology testing consumables market consists of two subsegments, namely, kits and reagents. The kits segment accounted for the largest share of the microbiology testing consumables market in 2014 and is expected to grow at the highest CAGR between 2014 and 2019.
The microbiology testing instruments market is sub-segmented into automated microbiology instruments, laboratory instruments and microbiology analyser. The laboratory instruments accounted for the largest share of the microbiology testing instruments market in 2014, whereas the automated microbiology instruments segment is expected to grow at the highest CAGR between 2014 and 2019. The laboratory instruments are further categorized into anaerobic gas systems, automated gram strainers, automated Petri dish fillers, autoclave sterilizers, bacterial colony counters, incubators, microbial air samplers and other laboratory instruments. The microbiology testing are further categorized into mass spectrometers, microscopes and molecular diagnostic instruments.
The applications included in this report are bloodstream infections, gastrointestinal diseases, periodontal diseases, respiratory diseases, sexually transmitted diseases, urinary tract infections and other diseases. The respiratory diseases segment accounted for the largest share of the market in 2014 and is expected to grow at the highest CAGR between 2014 and 2019. The geographic segments included in this report are North America, Europe, Asia and Rest of the World.
Increasing incidences of infectious diseases will be an important growth driver for the market. Furthermore, increased healthcare funding along with growing burden of new diseases will aid the growth of this market.
Major players in the microbiology testing market include Abbott Laboratories, Inc. (U.S.), Alere, Inc. (U.S.), bioMérieux SA (France), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.) Cepheid (U.S.), Danaher Corporation (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Siemens AG (Germany).
Browse Related Reports:
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology